Anupam Rasayan India is currently trading at RS 1319.85, up by 25.70 points or 1.99% from its previous close of RS 1294.15 on the BSE.

The stock opened at RS 1310.00 and has touched a high of RS 1333.30 and a low of RS 1310.00 so far. A total of 14,086 shares have been traded on the counter.

The BSE Group ‘A’ stock with a face value of RS 10 has recorded a 52-week high of RS 1333.30 on 09-Dec-2025 and a 52-week low of RS 600.95 on 28-Feb-2025.

During the past week, the stock touched a high of RS 1333.30 and a low of RS 1111.05. The current market capitalization of the company stands at RS 15,135.56 crore.

Promoter shareholding stands at 59.07%, while Institutions hold 9.00% and Non-Institutions hold 31.92%.

In a major strategic move, Anupam Rasayan India has signed a definitive agreement to acquire 100% equity stake in Jayhawk Fine Chemicals Corporation, a U.S.-based specialty chemicals company under the CABB group. The deal is valued at approximately $150 million, including equity value and existing loans payable to the exiting shareholders. With about $16 million of cash and cash-like items as of June 2025, the enterprise value stands at around $134 million.

The acquisition will be funded through a mix of internal accruals, debt, and quasi-equity from a leading global investment management firm managing over $100 billion in assets. The transaction is expected to be EPS accretive for Anupam Rasayan.

This deal marks a transformative step in the company’s long-term strategy to expand its global CDMO presence and strengthen its footprint in the U.S. and global specialty chemicals market.

Anupam Rasayan India is one of India’s leading companies engaged in custom synthesis and manufacturing of specialty chemicals.